In ₹ Crore except Per Share Latest Annual	NH FY26	APOLLOHOSP FY26	MAXHEALTH FY26	FORTIS FY26	Peer Average
Valuation — at last close
P/E	◆ 43.22×	60.72×	57.39×	54.70×	57.61× -25%
P/B	7.72×	12.44×	7.71×	◆ 5.76×	8.64× -11%
EV/EBITDA	◆ 23.11×	32.35×	38.17×	28.57×	33.03× -30%
Market Cap	₹35,038 Cr	₹1.18L Cr	₹82,828 Cr	₹56,992 Cr	₹85,912 Cr -59%
Growth
Revenue CAGR 3Y	20.39%	14.94%	◆ 22.43%	13.17%	16.85% +21%
Revenue CAGR 5Y	25.05%	19.03%	◆ 27.30%	17.76%	21.36% +17%
Net Income CAGR 3Y	9.94%	◆ 33.35%	9.34%	18.91%	20.53% -52%
Revenue YoY (latest Q)	◆ 73.01%	20.56%	20.31%	17.46%	19.44% +276%
Net Income YoY (latest Q)	16.50%	◆ 38.41%	-15.64%	2.26%	8.34% +98%
Profitability
EBITDA Margin	20.47%	14.94%	◆ 26.79%	22.84%	21.52% -5%
Net Income Margin	10.21%	7.94%	◆ 17.23%	11.66%	12.28% -17%
Return on Common Equity	19.74%	◆ 21.95%	14.33%	11.08%	15.79% +25%
Return on Capital Employed	13.94%	◆ 18.20%	12.63%	12.62%	14.48% -4%
Return on Assets	8.17%	◆ 9.35%	8.89%	7.18%	8.47% -4%
Credit & Quality
Total Debt/Equity	1.07×	0.57×	0.32×	◆ 0.28×	0.39× +174%
Interest Coverage	4.80×	6.44×	◆ 7.64×	5.20×	6.43× -25%
Scale — latest FY
Revenue / Total Income	₹7,896 Cr	₹25,229 Cr	₹8,373 Cr	₹9,128 Cr	₹14,243 Cr -45%
Net Income	₹806 Cr	₹2,003 Cr	₹1,442 Cr	₹1,064 Cr	₹1,503 Cr -46%
Total Assets	₹12,474 Cr	₹22,197 Cr	₹17,231 Cr	₹15,966 Cr	₹18,465 Cr -32%
EPS	₹39.67	₹135.04	₹14.83	₹13.8	₹54.56 -27%
Book Value per Share	₹222.02	₹659.26	₹110.43	₹131.07	₹300.25 -26%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.